Streetbeat News

Products Services

JOBY

Joby Aviation has completed its pre-production flight test program and is now moving to the next phase, focusing on for-credit flight testing using its production prototype aircraft.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:15 pm

CRL

Charles River Laboratories International, Inc. (NYSE:CRL) has launched a new portfolio of reference materials for AAV and LVV, aimed at streamlining Cell and Gene Therapy (CGT) research and development towards GMP quality. This includes six AAV serotypes and five LVV products, enhancing their CDMO offerings and supporting the transition from discovery to commercial stages in CGT.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:14 pm

DUOT

Duos Technologies Group, Inc. (NASDAQ:DUOT) has been granted a new patent for its railcar inspection technology, enhancing railcar inspection processes with AI and Machine Vision. This technology allows for efficient, automated inspections, potentially reducing the need for certain Federal Railroad Administration mandated inspections. The technology is already in use across North America, with plans for further expansion. This patent, along with a recent rail safety AI patent, positions Duos as a leader in railcar inspection innovation.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:13 pm

AMZN

CRWD

Amazon Web Services (AWS) and CrowdStrike have announced an expanded strategic partnership aimed at accelerating cybersecurity consolidation and cloud transformation. This collaboration is expected to enhance cloud security solutions, benefiting both companies by potentially increasing their market share in the cybersecurity and cloud services sectors.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:13 pm

TSLA

Mark Hawtin of GAM Investments expressed concerns about Tesla Inc.'s fundamentals and demand, despite its stock surge. He cited increasing competition in the EV market and potential issues from Tesla's aggressive price cuts. Tesla's Q1 earnings showed a 9% revenue decrease year-over-year, missing estimates, and the company announced layoffs as part of cost-cutting measures. Skepticism also surrounds Tesla's robo-taxis viability and its full self-driving software rollout in China.

Portfolio Pulse from Benzinga Neuro

May 02, 2024 | 12:12 pm

NDRA

ENDRA Life Sciences has announced the issuance of three new patents in Europe and two in China, marking a significant advancement in its intellectual property portfolio.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:12 pm

CDTG

CDT Environmental Technology Investment Holdings Limited (NASDAQ:CDTG) has been granted three new utility model patents by the China National Intellectual Property Administration (CNIPA). These patents are for innovations in waste treatment, including a sludge drying device, a wastewater treatment device for nitrogen and phosphorus removal, and a highly efficient waste anaerobic fermentation device. These developments are aimed at enhancing efficiency, reducing energy consumption, and minimizing environmental pollution in waste management.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:11 pm

IBM

IBM has announced the expansion of its software portfolio's availability to 92 countries in the AWS Marketplace, marking a significant increase in its global reach.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:11 pm

DARE

Daré Bioscience, Inc. (NASDAQ:DARE) has been selected as a spoke for the Investor Catalyst Hub, part of ARPA-H's nationwide health innovation network. This selection provides Daré with access to potential funding, faster award execution, opportunities to influence ARPA-H's priorities in women's health, and valuable networking opportunities. The company's CEO, Sabrina Martucci Johnson, expressed honor in participating in ARPA-H's Sprint for Women's Health and looks forward to accelerating women's health care research.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:10 pm

LFMD

LifeMD, Inc. (NASDAQ:LFMD) partners with Withings Health Solutions to enhance GLP-1 weight-loss patient care by providing advanced in-home health monitoring devices. This strategic partnership aims to improve patient outcomes through real-time data for clinicians, supporting weight management with online consultations, prescriptions, and laboratory testing. The use of Withings' Body Pro 2 scale and BPM Connect Pro blood pressure monitor sets a new standard in virtual care, enabling better clinical decisions and long-term health improvements.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:09 pm